Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
90 participants
OBSERVATIONAL
2022-10-01
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Amputation Associated Factors and Prediction Model in Diabetic Foot Patients
NCT05186519
Assessment of Revascularization in Plantar Foot of Diabetic Patients Pre and Post Angioplasty Using Spatial Frequency Domain Imaging
NCT07097857
Appropriate Strategy of Surgical Treatment in Ischemic Diabetic Foot
NCT04709887
Morphological and Functional Evaluation of Adult Flat Foot Before and After Corrective Surgery
NCT04174482
Clinical and Mechanistic Study of Transverse Tibial Transport in Complex Foot Ulcers
NCT05704075
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
computed tomographic perfusion
The recruited patients would complete both pre- and post-operative computed tomographic perfusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* CLI patients with Fontaine grade III-IV or Rutherford grade 4-6 and underwent a successful revascularization;
* Patients completed both pre- and post-operative CTP workups;
* Patients signed the informed consent form and be able to complete the clinical follow-up for 12 months.
Exclusion Criteria
* Patients with Heart failure (NYHA III/IV)/right to left shunt heart disease/severe aortic and mitral insufficiency/acute coronary syndrome/malignant arrhythmia/severe pulmonary hypertension (pulmonary artery pressure at least 90 mmHg)/moderate to severe renal insufficiency (creatinine clearance rate\<60 ml/min)
* Any allergic constitution;
* Pregnancy and childbirth;
* Life expectancy\<12 months.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhijun Bao
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wan Zhang, PH.D.
Role: PRINCIPAL_INVESTIGATOR
Huadong Hospital affiliated to Fudan University, Shanghai, China, 200040
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hua Dong Hospital Affiliated to Fu Dan University
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022KW
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.